User:Mr. Ibrahem/Crisaborole

Crisaborole, sold under the brand name Eucrisa among others, is a medication used to treat atopic dermatitis (eczema). It is used for mild to moderate disease in those over the age of two months. It is applied to the skin.

Common side effects include burning or stinging at the site of application. Other side effects may include allergic reactions. It is a phosphodiesterase 4 (PDE-4) inhibitor and believed to work by blocking the release of cytokines.

Crisaborole was approved for medical use in the United States in 2016 and Europe in 2020. In the United States a tube of 60 grams costs about US$680 as of 2022. While it is approved in the United Kingdom, it is not commercially available as of 2022.